ArticleNature biomedical engineering2026
Large-scale multi-sequence pretraining for generalizable MRI analysis in versatile clinical applications.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Design with women in mind.Nature biomedical engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Multi-sequence magnetic resonance imaging (MRI) is essential for clinical diagnosis because it enables comprehensive characterization of complex anatomy. However, its substantial heterogeneity limits the generalizability of deep learning models and hinders clinical translation. Here we present MARS, a large-scale MRI foundation model with a novel pretraining strategy that disentangles anatomy-invariant features from sequence-specific variations to learn robust and generalizable representations for diverse clinical applications. We collected 64 datasets spanning 10 anatomical structures and multiple MRI sequences. Among these, 336,476 volumetric scans from 34 datasets (8 public and 26 private) were curated to build a large multi-organ, multi-sequence MRI pretraining corpus. We further established a benchmark of 44 downstream tasks covering diagnosis, segmentation, registration, progression prediction and report generation. MARS ranked first in 41 of 44 benchmarks, with statistically significant improvements. Its strong performance on heterogeneous and external datasets underscores MARS as a scalable foundation for versatile real-world multi-sequence MRI analysis.
Identifiers
42443444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.